The company is voluntarily recalling all batches of irbesartan tablets in 75-milligram , 150-mg and 300-mg strengths, as well as irbesartan/hydrochlorothiazide tablets in 150-mg/12.5-mg and 300-mg/12.5-mg strengths.
Lupin said it stopped marketing the tablets in January. Both types are used to treat hypertension, orAn analysis during the company’s testing process showed that some tested batches -- but not finished product batches -- were above the limit for N-nitrosoirbesartan, an impurity that may cause cancer.
“Although Lupin has received no reports of illness that appear to relate to this issue, the company, out of an abundance of caution, is recalling all batches,” according to the notice. The company received four reports of illness from irbesartan tablets and no reports of illness from irbesartan/hydrochlorothiazide tablets between Oct. 8, 2018, and Sept. 30, 2021, which includes the earliest date of shipment from the manufacturing site for any of the affected batches. The four illnesses weren’t related to the impurity, the company said.
The recall notice includes lot numbers for the 30- and 90-count bottles that went to U.S. wholesalers, drug chains, mail order pharmacies, and supermarkets nationwide between 2018 and 2020. Lupin is arranging for the return of all the recalled product lots.or doctor to arrange a different treatment, according to the notice.or quality problems to the FDA’s MedWatch Adverse Event Reporting Program, either online, by mail, or by fax. Instructions are included in the recall notice.
Well .....what are they?
How often do inspectors visit manufacturing site if this can happen?
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Source: CNBC - 🏆 12. / 72 Read more »
Source: FashionCanada - 🏆 35. / 63 Read more »
Fauci: J&J vaccine 'should have been a two-dose vaccine'Fauci said FDA panel's recommendation shows J&J vaccine 'should have been a two-dose vaccine to begin with' 7 terms served ☝🏼 Fauci说，FDA小组的建议显示强生疫苗“从一开始就应该是两剂疫苗” Thanks for telling people now. But shouldn't there have been a more objective presentation earlier of Janssen's efficacy of 66.1% instead of promoting its higher US only efficacy, as Fauci did, or its higher efficacies against severe disease or hospitalization, as Fauci also did.
Source: BusinessInsider - 🏆 729. / 51 Read more »
Source: latimes - 🏆 11. / 82 Read more »
Source: CNN - 🏆 4. / 95 Read more »
Source: hellomag - 🏆 24. / 68 Read more »